Member Info for TrickyEFC

Just a lil over half a mil shares

I took somemore 😁😁

Am tempted to get somemore. They Will take 10 million off me

Any

Jan-25 08:29:00 1.431 1,000,000 Unknown* 14.31k

And another

These buy orders.

Where is the seller and the new buyer RNs.

Time Trade Prc Volume Buy/Sell Value

27-Jan-25 08:23:53 1.444 1,006,682 Unknown* 14.54k O

27-Jan-25 08:20:13 1.44 1,074,204 Unknown* 15.47k

The buy order price point is constantly rising day on day

Raven.

06 1.4395 1,000,000 Unknown* 1.40 1.50 14.40k

Buys sir buys not sells

Not ready so lots of buys showing red currently

Popped it's head out

Bline they have a lot of different pathways moving forward.

Wonder if this will finally wake the market up to what's going on at solvonis

Nice RNs of the companies current position.

AWKN-001 is an investigational, novel combination therapy consisting of an N-methyl-D-aspartate ("NMDA") receptor-modulating drug (ketamine) delivered intravenously ("IV") in combination with copywritten relapse prevention cognitive behavioural therapy ("CBT") for the treatment of severe AUD in the UK and potentially the EU.

Phase 2 results demonstrated a 50% reduction in heavy drinking days in the 6 months post treatment versus the placebo. The phase 2 results also demonstrated an on average 86% abstinence rate in the 6 months post treatment versus 2% abstinence pre-trial.

Current status: AWKN-001 is in a Phase 3 clinical trial in the UK across 9 NHS Trusts. The Phase 3 trial is co-funded by a partnership between the UK's Medical Research Council (the "MRC"), the National Institute for Health and Care Research (the "NIHR"), and Awakn. Awakn's costs are capped at £800,000. The trial is managed the University of Exeter Clinical Trials Unit.

can't even be ****d reading it

as unless they found a leprechaun with his stash it's not getting me even 😆😆😆

Be interesting to see how it plays out short term once we pass the years high.

Ask yourself Will investors be of the mind set to jump out on a years high with everything that's currently going on

Could be epic day tomorrow to start the week.

We need to breeze past 2.5p for current nav value for starters and then we can move to 3/4p near term on potential.

Remember this is just revving up

Regardless of any of the 17 investments at this time it's all about buying potential.

Mannan posted

2025: The AI market is projected to reach $243.70 billion

2030: The AI market is projected to reach $826.70 billion

2034: The AI market is projected to reach $3,680.47 billion

The programme for the evening is as follows:

4:30pm Interview with Fund Manager, Katen Patel

5:00pm Company presentation from Helios Underwriting plc

5:40pm Company presentation from Solvonis Therapeutics (formerly Graft Polymer)

6:20pm Educational session

6:35pm Company presentation from Cohort plc

7:20pm BASH (Buy, Avoid, Sell, Hold) Panel featuring Kevin Taylor and Mark Simpson

Some big action

Jan-25 08:12:44 1.2225 2,000,000 Unknown* 24.45k O

23-Jan-25 10:23:00 1.3023 2,000,000 Unknown* 26.05k